The higher mutation burden observed in our cohort, alongside the enrichment of AXIN1 and KRAS mutations, suggests the presence of distinct oncogenic pathways in the development of HCC, which may be influenced by regional genetic and environmental factors. This evidence concerns the gene KRAS and hepatocellular carcinoma.